NCT05636618
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors No drug interventions treatment 1 / 2 recruiting NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes No drug interventions supportive_care Not Available recruiting NCT01782443
Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors treatment 2 completed NCT02754297
Personalized PRRT of Neuroendocrine Tumors treatment 2 active_not_recruiting NCT00328497
A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors treatment 2 completed NCT00412061
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor treatment 3 completed NCT04993261
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors No drug interventions diagnostic 0 active_not_recruiting NCT02399215
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors treatment 2 completed NCT01466036
Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors treatment 2 completed NCT04039516
Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy treatment 2 not_yet_recruiting NCT01175096
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor treatment 1 / 2 unknown_status NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT05361668
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome treatment 2 active_not_recruiting NCT04197310
Cabozantinib and Nivolumab for Carcinoid Tumors treatment 2 completed NCT02038738
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors diagnostic 1 / 2 unknown_status NCT03420521
Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors treatment 2 terminated NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT01024387
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors treatment 2 completed NCT02431715
18F-FDOPA PET in Neuroendocrine Tumours No drug interventions Not Available Not Available no_longer_available NCT00657332
Clinical and Pathologic Studies in Neuroendocrine Tumors No drug interventions Not Available Not Available withdrawn NCT03723499
Endoscopic Treatment of Bronchial Carcinoid Tumors No drug interventions Not Available Not Available completed NCT01398306
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. No drug interventions Not Available Not Available completed NCT00804336
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors treatment 1 completed NCT00780663
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma treatment 2 completed NCT01435122
A Study of Axitinib in Advanced Carcinoid Tumors treatment 2 completed NCT01039922
SwissNET - a Registry for Neuroendocrine Tumours in Switzerland No drug interventions Not Available Not Available recruiting NCT03375320
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors treatment 3 active_not_recruiting NCT00446082
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease treatment 1 completed NCT00942682
Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors treatment 1 completed NCT05477576
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy treatment 3 recruiting NCT04915144
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs treatment 2 withdrawn NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging No drug interventions Not Available Not Available unknown_status NCT02859064
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres treatment 2 terminated NCT01253161
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) treatment 2 completed NCT01373736
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors No drug interventions diagnostic 3 unknown_status NCT01619865
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors diagnostic 1 / 2 completed NCT00580320
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma treatment 1 completed NCT02441062
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors diagnostic 2 completed NCT00947167
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors treatment 2 terminated NCT00088595
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors treatment 2 completed NCT01980732
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors No drug interventions Not Available Not Available no_longer_available NCT02359500
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) diagnostic 1 terminated NCT02575300
Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors treatment 2 completed NCT00227136
Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion No drug interventions diagnostic 3 terminated NCT02795858
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors treatment 2 active_not_recruiting NCT01731925
A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors treatment 2 unknown_status NCT02177773
GA-68 DOTA-TOC of Somatostatin Positive Malignancies diagnostic 1 / 2 terminated NCT02441088
Theranostics: 68GaDOTATOC and 90YDOTATOC treatment 2 active_not_recruiting